The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1240

Because it comes across as disingenous, and untrustworthy. Had they been open, transparent and gone onto explain why they think the bulbous form makes any difference, the market would feel at least informed.

Doing it this way reeks of trying to hide the fact by glossing over, and providing a cursory look over there 'it was always expected' statement.

I tend to agree with the pig and JJ that this was in fact material information. Look at the sell off today, i can bet 90% of that is due to this fact. If PAA are bow choosing to communicate openly and transparently with shareholders, perhaps they need an ASIC complaint as a reminder of responsibilities.